Spring 2012
Cancer Genetics and Genomics Forum
2240
CIEMAS
Mondays
1:00pm
(Unless
otherwise noted)
|
Date |
Presenter |
Topic |
Slides |
|
Jan.
23 |
Dr. Sandeep Dave |
Microarrays,
Deep Sequencing and Beyond: The Promise and Peril of High Throughput
Technologies in Cancer |
|
|
Jan.
30 |
No Meeting |
|
|
|
Feb.
6 |
Dr. Chuan-Yuan Li |
Phoenix
Rising and Wheel of Life: Redefining the Roles Caspases in Tumor Therapy, Tissue
Regeneration, and Stem Cells |
|
|
Feb.
13 |
Dr. Raluca Gordan |
Applications
of Protein Binding Microarrays to Cancer Genomics |
|
|
Feb.
20 |
Dr. Ashley Chi |
Microenvironmental Stresses and
Nutrient Requirement of Tumors |
|
|
Feb.
27 |
Dr. Herbert Hurwitz |
Biomarkers
for Anti-VEGF Therapy: An Update |
|
|
Mar.
5 |
Dr. Matthew
Hirschey |
Protein
Acetylation Induces Hepatocellular
Carcinoma |
|
|
Mar.
12 |
Dr. Sam Mbulaiteye (Natl. Cancer
Inst.) |
Endemic
,Sporadic and AIDS-related Burkitt Lymphoma: Epidemiological Patterns May Be Clue
to Molecular Heterogeneity |
|
|
Mar.
19 |
Dr. Micah Luftig |
Studies
at the Oncogenic Virus/Host Interface: Dynamic Regulation of Epstein-Barr
Virus-Mediated B Cell Immortalization |
|
|
Mar.
26 |
Dr. Terry Furey,
UNC Chapel Hill |
Integrating
Genomic Data in Complex Disease Analysis |
|
|
April
2 |
Dr. Sayan Mukherjee |
Integrating
Genetic and Gene Expression Evidence into Genome-wide Association Analysis of
Gene Sets and a Bayesian Mixed Effects Model of Differential Expression for RNAseq Data |
|
|
April
9 |
NO CG&G Forum |
|
|
|
April
16 |
Dr. David Kirsch |
Using
a Genetically Engineered Mouse Model of Sarcoma to Identify miRNAs that Regulate Metastasis |
|
|
April
23 |
Dr. W. Kimryn
Rathmell, UNC Chapel Hill Lineberger Comprehensive Cancer Center |
Tumor
Heterogeneity in Renal Cell Carcinoma |
|
|
April
30 |
Dr. William Kim, UNC Chapel Hill Lineberger Comprehensive Cancer Center |
Erythropoietin
and Solid Tumorigenesis |
|
|
May
7 |
Dr. Charles Perou, UNC Chapel Hill Lineberger Comprehensive Cancer Center |
Therapeutic
Implications of the Molecular Portraits of Breast Cancer |
|
|
May
14 |
Dr. Donald Fox |
Roles
for Polyploidy in De-stabilizing the Genome |
|
|
May
21 |
Dr. Michael Kastan Executive Director,
Duke Cancer
Institute |
DNA
Damage Responses: Bedside to Bench to Bedside” |
|
|
June
4 |
Dr. Joseph Lucas |
TBD |
|